USA Financial Formulas’s Nu Skin NUS Stock Holding History

USA Financial Formulas’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7	Closed	–	–	421
2021 Q1	$0	Sell	7 -7,984	-100%	-$435K	﹤0.01%	402
2020 Q4	$437K	Buy	+7,991	New	+$420K	0.35%	81

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

USA Financial Formulas's NUS Position: Q2 2021 in Review

USA Financial Formulas sold out of Nu Skin (NUS) in Q2 2021, closing a stake of 7 shares.

USA Financial Formulas first reported a position in NUS in Q4 2020 and held it in 2 quarters. The position peaked at $437K in Q4 2020. 273 funds tracked by Wall St. Rank hold NUS as of Q2 2021.

USA Financial Formulas reported no remaining Nu Skin position as of Q2 2021 after selling out during the quarter.
USA Financial Formulas sold 7 Nu Skin shares in Q2 2021.
USA Financial Formulas first reported a position in Nu Skin in Q4 2020 and held it in 2 quarters.
USA Financial Formulas's Nu Skin position peaked at $437K in Q4 2020.
273 funds tracked by Wall St. Rank held Nu Skin as of Q2 2021.

Based on USA Financial Formulas's 13F filing for Q2 2021, filed 29 Jul 2021.